News from can-fite biopharma ltd

Jul 21, 2014, 07:00 ET

Can-Fite CEO to Deliver Scientific Presentation and Serve on Expert Panel at Purines 2014 in Bonn, Germany on July 23-27, 2014

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that...

Jul 10, 2014, 07:00 ET

Can-Fite's CF102 Approved for Compassionate Use in Israel for Liver Cancer Patient

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that...

Jun 19, 2014, 07:00 ET

Can-Fite to Exhibit at Bio International Convention in San Diego on June 23 - 26, 2014

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Jun 17, 2014, 07:00 ET

Can-Fite Completes Patient Enrollment in its Phase II/III Psoriasis Trial; Final Results are expected in Q1 2015

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that...

Jun 10, 2014, 07:00 ET

Can-Fite to Participate in Newport Coast Securities Conference in New York & ROTH Conference in London

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Jun 09, 2014, 07:00 ET

Can-Fite Subsidiary OphthaliX Provides an Update on its Clinical Developments and Strategic Plans

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Jun 02, 2014, 07:00 ET

Can-Fite Announces that the US FDA has Agreed with its Phase II Liver Cancer Protocol

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

May 30, 2014, 16:32 ET

Can-Fite Announces 2014 Annual General Meeting

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

May 29, 2014, 07:00 ET

Can-Fite Reports First Quarter 2014 Results

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

May 15, 2014, 07:00 ET

Can-Fite to Exhibit at MIXiii Biomed Israel Innovation Conference

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that...

May 07, 2014, 11:41 ET

Can-Fite Receives Patent in European Union for Treatment of Liver Function Following Surgery

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Apr 29, 2014, 07:00 ET

Can-Fite Submits Protocol to U.S. FDA for Phase II Liver Cancer Study

Can-Fite BioPharma Ltd. (NYSE MKT:CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Apr 21, 2014, 07:00 ET

Can-Fite Initiates the Development of an A3AR Biomarker Test Kit to Predict Patients' Response to Company's Drugs

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Mar 31, 2014, 14:28 ET

Can-Fite Files 2013 Annual Report on Form 20-F

 Can-Fite BioPharma Ltd. (TASE: CFBI), (NYSE MKT: CANF), a biotechnology company with a pipeline of proprietary small molecule...

Mar 25, 2014, 07:00 ET

Can-Fite to Present at the 9th International Congress of Autoimmunity

 Can-Fite BioPharma Ltd. (TASE:CFBI), (NYSE MKT:CANF),  a biotechnology company with a pipeline of proprietary small molecule...

Mar 17, 2014, 07:00 ET

‏Can-Fite: Phase II Study Protocol to Treat Patients with Advanced Liver Cancer with CF102 has been Approved by the IRB in Israel

 Can-Fite BioPharma (TASE: CFBI), (NYSE MKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs...

Mar 10, 2014, 12:44 ET

Can-Fite Completes $5 Million Private Placement

 Can-Fite BioPharma Ltd. (TASE: CFBI), (NYSE MKT: CANF),  a biotechnology company with a pipeline of proprietary small molecule drugs...

Mar 03, 2014, 07:00 ET

Can-Fite Announces the Addition of A Key Opinion Leader to Boost its Rheumatoid Arthritis CF101 Program

 Can-Fite BioPharma  Ltd. (TASE:CFBI), (NYSE MKT:CANF), a biotechnology company with a pipeline of proprietary small molecule...

Feb 27, 2014, 07:00 ET

Can-Fite to Present at the 26th Annual ROTH Capital Conference

 Can-Fite BioPharma Ltd. (TASE:CFBI), (NYSE MKT:CANF),  a biotechnology company with a pipeline of proprietary small molecule...

Feb 25, 2014, 07:00 ET

Can-Fite Granted Patent on the Manufacturing of CF101 in Japan

 Can-Fite BioPharma  Ltd. (TASE: CFBI), (NYSE MKT: CANF), a biotechnology company with a pipeline of proprietary small molecule drugs...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge